Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Immatics Biotechnologies GmbH
DescriptionVaccine containing 13 tumor-associated peptides (TUMAPs)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationColorectal cancer
Indication DetailsTreat advanced colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today